PLX vs XPO · P/E 31, rev $53.6M vs P/E 69, rev $2.35B
Protalix Biotherapeutics Inc (PLX) versus XPO Logistics Inc (XPO) — a side-by-side from cached financials, not a winner call.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
XPO Logistics Inc (XPO) is a trucking company listed on NYSE.
Latest reported PLX revenue for 2026-06-30 was $53.6M. Net income was $22.1M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Latest reported XPO revenue for 2026-06-30 was $2.35B. Net income was $162.0M. Revenue was up 12.4% from 2026-03-31 to 2026-06-30. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
PLX currently screens at market cap $122.6M and trailing P/E 30.8. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
Not investment advice. Open the PLX and XPO stock pages for the full models.
Not investment advice.